EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H29F2N9O3 |
| Net Charge | 0 |
| Average Mass | 541.563 |
| Monoisotopic Mass | 541.23614 |
| SMILES | Nc1nn2cc(F)cnc2c1C(=O)Nc1cncc(F)c1N1CCC(C(=O)N2CCN(C3COC3)CC2)CC1 |
| InChI | InChI=1S/C25H29F2N9O3/c26-16-9-30-23-20(22(28)32-36(23)12-16)24(37)31-19-11-29-10-18(27)21(19)34-3-1-15(2-4-34)25(38)35-7-5-33(6-8-35)17-13-39-14-17/h9-12,15,17H,1-8,13-14H2,(H2,28,32)(H,31,37) |
| InChIKey | QAYHKBLKSXWOEO-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC 2.7.11.1), a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine. EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor An inhibitor of phosphatidylinositol 3-kinase, EC 2.7.1.137, a family of related enzymes capable of phosphorylating the 3 position hydroxy group of the inositol ring of a phosphatidylinositol. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| gartisertib (CHEBI:231616) has role antineoplastic agent (CHEBI:35610) |
| gartisertib (CHEBI:231616) has role EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor (CHEBI:50914) |
| gartisertib (CHEBI:231616) has role EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor (CHEBI:50925) |
| gartisertib (CHEBI:231616) is a N-acylpiperazine (CHEBI:46844) |
| gartisertib (CHEBI:231616) is a aromatic amine (CHEBI:33860) |
| gartisertib (CHEBI:231616) is a organofluorine compound (CHEBI:37143) |
| gartisertib (CHEBI:231616) is a oxetanes (CHEBI:38784) |
| gartisertib (CHEBI:231616) is a piperidinecarboxamide (CHEBI:48592) |
| gartisertib (CHEBI:231616) is a primary amino compound (CHEBI:50994) |
| gartisertib (CHEBI:231616) is a pyrazolopyrimidine (CHEBI:38669) |
| gartisertib (CHEBI:231616) is a pyridines (CHEBI:26421) |
| gartisertib (CHEBI:231616) is a secondary carboxamide (CHEBI:140325) |
| IUPAC Name |
|---|
| 2-amino-6-fluoro-N-[5-fluoro-4-(4-{[4-(oxetan-3-yl)piperazin-1-yl]carbonyl}piperidin-1-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| INNs | Source |
|---|---|
| gartisertibum | WHO MedNet |
| gartisertib | WHO MedNet |
| gartisertib | WHO MedNet |
| gartisertib | WHO MedNet |
| Synonyms | Source |
|---|---|
| 2-amino-6-fluoro-N-(5-fluoro-4-(4-(4-(oxetan-3-yl)piperazine-1-carbonyl)piperidin-1-yl)pyridin-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide | SUBMITTER |
| M-4344 | SUBMITTER |
| VX-803 | SUBMITTER |
| M4344 | ChEBI |
| M 4344 | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| DB18770 | DrugBank |
| Registry Numbers | Sources |
|---|---|
| CAS:1613191-99-3 | DrugBank |
| Citations |
|---|